Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMA202 |
Trade Name | |
Synonyms | IMA-202|IMA 202 |
Drug Descriptions |
IMA202 is a TCR engineered T-cell therapy, which consists of autologous patient-derived T-cells that are modified to express T-cell receptors that recognizes patient-specific tumor associated antigens (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C153218 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMA202 | IMA202 | 0 | 1 |